Sonnie Kang

Sonnie Kang is an experienced commercial strategy leader currently serving as the Commercial Strategy Lead at Apnimed since March 2024, focusing on bringing the first oral pharmaceutical treatment for obstructive sleep apnea to market. Prior to this role, Kang was the Commercial Lead for btwelve at Klick, providing strategic support for early-phase startups in the pharma and health tech sectors from November 2022 to March 2024. Kang also held the position of Client Service Lead at Katalyst, a Klick Company, from May 2017 to September 2022. Earlier experience includes serving as the Global Lead for Botox Cosmetics at Allergan, where responsibilities involved line extension and competitive intelligence, and as SVP, Managing Director at Biolumina, focusing on oncology and hematology. Kang holds a BS in Pharmacy from Arnold & Marie Schwartz College of Pharmacy and a BS in Chemistry from the University of Maryland.